{
    "2021-09-11": [
        [
            {
                "time": "2021-09-01",
                "original_text": "Biden Courts Businesses; Moscow Cases Jump: Virus Update",
                "features": {
                    "keywords": [
                        "Biden",
                        "Courts",
                        "Businesses",
                        "Moscow",
                        "Cases",
                        "Jump",
                        "Virus",
                        "Update"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "business"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "U.S. has administered 379.4 mln COVID-19 vaccine doses, CDC says",
                "features": {
                    "keywords": [
                        "U.S.",
                        "administered",
                        "379.4",
                        "mln",
                        "COVID-19",
                        "vaccine",
                        "doses",
                        "CDC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "Here's a Great Reason to Buy Pfizer Stock (and It Has Nothing to Do With the COVID Vaccine)",
                "features": {
                    "keywords": [
                        "Great",
                        "Reason",
                        "Buy",
                        "Pfizer",
                        "Stock",
                        "Nothing",
                        "Do",
                        "COVID",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "3 Recession-Ready Stocks to Buy in September",
                "features": {
                    "keywords": [
                        "Recession-Ready",
                        "Stocks",
                        "Buy",
                        "September"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Beat",
                        "Sanofi",
                        "Regeneron",
                        "Eczema",
                        "Market"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "3 Smartest Big Pharma Stocks to Buy in September",
                "features": {
                    "keywords": [
                        "Smartest",
                        "Big",
                        "Pharma",
                        "Stocks",
                        "Buy",
                        "September"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "Here's Where Novavax May Beat Moderna and Pfizer",
                "features": {
                    "keywords": [
                        "Novavax",
                        "May",
                        "Beat",
                        "Moderna",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}